Member-only story
Classic psychedelics are linked to general health
Surprise! One day psychedelics may become a new fitness trend.
The effects of therapeutic psychedelic treatment on mood disorders are receiving significant scientific attention. Psilocybin is currently being tested in several clinical trials for the treatment of mood disorders. However, arguably, even broader health benefits of classic psychedelics may include weight, cardiovascular disease, and cancer risk.
A groundbreaking new paper just published in March looked into the presumable broader health benefit of classic psychedelics. Three years of data, on over 170 000 people provided by the National Survey on Drug Use, was recently examined by a team of researchers from the Department of Sociology of the University of Oxford. Otto Simonsson and his team were determined to review a relationship between classic psychedelics and overall health.
Classic psychedelics are a subcategory with little evidence of physiological toxicity and carry a low risk if administered in the health care context and environment.
These substances act at the 5-HT2A receptor, a receptor that belongs to the family of serotonin receptors. In mental health, the…
